Issue Date: August 4, 2014
Emulate Is Launched For Organs On Chips
Scientists at Harvard University’s Wyss Institute for Biologically Inspired Engineering have secured $12 million in venture capital for the launch of Emulate, a company seeking to commercialize a polymer chip with automated instrumentation and software that predicts human responses to medicines, chemicals, and toxins.
Emulate is betting that its Organs-on-Chips platform will expedite laboratory testing of drugs, reduce the need for animal testing, and advance personalized medicine research. The size . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society